• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[使用他汀类药物作为预防年龄相关性黄斑变性(AMD)的一种保护形式]

[Use of statins as a form of protection against age-related macular degeneration (AMD)].

作者信息

Drobek-Słowik Monika, Karczewicz Danuta, Safranow Krzysztof, Jakubowska Katarzyna, Chlubek Dariusz

机构信息

Z Kliniki Okulistyki Pomorskiej Akademii Medyczej w Szczecinie.

出版信息

Klin Oczna. 2008;110(1-3):50-4.

PMID:18669084
Abstract

PURPOSE

To evauate the association between use of lipid-lowering medications and occurrence of age-related macular degeneration (AMD).

MATERIAL AND METHODS

91 patients with dry and 55 with exudative type AMD diagnosed with fundus fluorescein angiography were included to the study. Control group for the study Consisted of 68 participants without AMD. Data regarding use of cholesterol-lowering medications were collected with details.

RESULTS

In control group we noted significantly higher percentage of statin users compared to patients with AMD.

CONCLUSIONS

Use of statins may be a protective factor against age-related macular degeneration.

摘要

目的

评估降脂药物的使用与年龄相关性黄斑变性(AMD)发生之间的关联。

材料与方法

该研究纳入了91例经眼底荧光血管造影诊断为干性AMD的患者和55例渗出性AMD患者。研究的对照组由68名无AMD的参与者组成。收集了有关降胆固醇药物使用的详细数据。

结果

在对照组中,我们注意到使用他汀类药物的百分比显著高于AMD患者。

结论

使用他汀类药物可能是预防年龄相关性黄斑变性的一个保护因素。

相似文献

1
[Use of statins as a form of protection against age-related macular degeneration (AMD)].[使用他汀类药物作为预防年龄相关性黄斑变性(AMD)的一种保护形式]
Klin Oczna. 2008;110(1-3):50-4.
2
Recent statin use and 1-year incidence of exudative age-related macular degeneration.近期他汀类药物的使用与渗出性年龄相关性黄斑变性的 1 年发生率。
Am J Ophthalmol. 2010 Jun;149(6):955-958.e1. doi: 10.1016/j.ajo.2009.12.037. Epub 2010 Mar 26.
3
The use of cholesterol-lowering medications and age-related macular degeneration.降胆固醇药物的使用与年龄相关性黄斑变性
Ophthalmology. 2005 Mar;112(3):488-94. doi: 10.1016/j.ophtha.2004.10.027.
4
Statin and aspirin therapy are associated with decreased rates of choroidal neovascularization among patients with age-related macular degeneration.他汀类药物和阿司匹林治疗与年龄相关性黄斑变性患者脉络膜新生血管形成率降低有关。
Am J Ophthalmol. 2004 Apr;137(4):615-24. doi: 10.1016/j.ajo.2003.10.025.
5
Statins do not decrease the risk for wet age-related macular degeneration.他汀类药物不能降低湿性年龄相关性黄斑变性的风险。
Curr Eye Res. 2009 Apr;34(4):304-10. doi: 10.1080/02713680902741670.
6
[Eye's risk factors in age-related macular degeneration (AMD). Part I].[年龄相关性黄斑变性(AMD)中的眼部危险因素。第一部分]
Klin Oczna. 2008;110(1-3):40-3.
7
[Eye's risk factors in age-related macular degeneration (AMD). Part II].[年龄相关性黄斑变性(AMD)中的眼部危险因素。第二部分]
Klin Oczna. 2008;110(1-3):44-9.
8
Statins and the long-term risk of incident age-related macular degeneration: the Blue Mountains Eye Study.他汀类药物与年龄相关性黄斑变性发病的长期风险:蓝山眼研究
Am J Ophthalmol. 2007 Apr;143(4):685-7. doi: 10.1016/j.ajo.2006.11.021. Epub 2006 Dec 20.
9
The time pattern of bilateral exudative age-related macular degeneration.双侧渗出性年龄相关性黄斑变性的时间模式。
Acta Ophthalmol Scand. 2005 Jun;83(3):333-6. doi: 10.1111/j.1600-0420.2005.00451.x.
10
Risk of macular degeneration with statin use should be interpreted with caution.使用他汀类药物引发黄斑变性的风险应谨慎解读。
BMJ. 2001 Dec 1;323(7324):1308.

引用本文的文献

1
Statins for age-related macular degeneration.用于年龄相关性黄斑变性的他汀类药物。
Cochrane Database Syst Rev. 2016 Aug 4;2016(8):CD006927. doi: 10.1002/14651858.CD006927.pub5.
2
Statins for age-related macular degeneration.用于年龄相关性黄斑变性的他汀类药物。
Cochrane Database Syst Rev. 2015 Feb 11;2(2):CD006927. doi: 10.1002/14651858.CD006927.pub4.
3
Elevated high-density lipoprotein cholesterol and age-related macular degeneration: the Alienor study.高密度脂蛋白胆固醇升高与年龄相关性黄斑变性:阿列诺研究
PLoS One. 2014 Mar 7;9(3):e90973. doi: 10.1371/journal.pone.0090973. eCollection 2014.
4
Age-related macular degeneration and protective effect of HMG Co-A reductase inhibitors (statins): results from the National Health and Nutrition Examination Survey 2005-2008.年龄相关性黄斑变性与HMG Co-A还原酶抑制剂(他汀类药物)的保护作用:来自2005 - 2008年美国国家健康和营养检查调查的结果
Eye (Lond). 2014 Apr;28(4):472-80. doi: 10.1038/eye.2014.8. Epub 2014 Feb 7.
5
Statins for age-related macular degeneration.用于年龄相关性黄斑变性的他汀类药物。
Cochrane Database Syst Rev. 2012 Mar 14;3(3):CD006927. doi: 10.1002/14651858.CD006927.pub3.
6
The controversy over the association between statins use and progression of age-related macular degeneration: a mini review.他汀类药物使用与年龄相关性黄斑变性进展之间关联的争议:一篇综述。
Clin Ophthalmol. 2010 Aug 9;4:865-9. doi: 10.2147/opth.s12869.
7
Statins for age-related macular degeneration.用于年龄相关性黄斑变性的他汀类药物。
Cochrane Database Syst Rev. 2009 Jul 8(3):CD006927. doi: 10.1002/14651858.CD006927.pub2.